Chemicals

'Reverse patent trolls' plague big pharma in China

The high invalidation rate for life science patents in China has created a headache for drug companies and a money-making opportunity for enterprising individuals

'Reverse patent trolls' plague big pharma in China
8 Apr 2019

Reforms seek to boost South Korea's patent market

Firms welcomed tougher measures against infringers at IPBC Korea 2019 last week, but there are concerns about a recent initiative to attract more foreign litigants through the use of English-language hearings

5 Apr 2019

Analysis of Fujifilm’s portfolio shows R&D strategy has opened doors to high-growth industries

The Japanese photography and imaging company has focused on developing peripheral technologies to expand into the medical and pharmaceuticals sectors; but while its holdings have increased in quality over the years, it still has a way to go

Latest

View all
4 Apr 2019

Toyota offers 24,000 patents royalty-free in bid to boost hybrid business

The Japanese automaker is ‘opening up’ patents related to hybrid electric vehicle technology that it has previously licensed to Nissan, Ford, Subaru and Mazda, in a move that expands on its previous fuel cell pledge Read more

1 Apr 2019

IP-related statistics from the recent past

A selection of recently reported facts and figures. Read more

31 Mar 2019

The owners of the biggest patent portfolios in the United States revealed

The IAM/ktMINE Patent 100 is back to give the latest rundown on the companies that own the largest patent portfolios in the United States. While Samsung retains a vice-like grip on the top spot, there is much to analyse further down the rankings as we see new players entering the 100, different sectors doubling down on their patenting efforts and some notable fallers. Read more

31 Mar 2019

Intellectual property 4.0

As the fourth industrial revolution gets underway, operating companies need to ensure that their IP strategies are fit for a rapidly changing technological landscape. Read more

News

View all
12 Mar 2019

Europe’s patent landscape in six charts 

The EPO’s annual report for 2018 was published today and shows that filing levels are up, grants have surged, the US leads, China slows and Siemens is number one Read more

6 Mar 2019

The state of play in the global IP market

IAM's annual benchmarking survey is designed to identify the key concerns of senior decision makers in areas such as deal-making, valuation, patent office performance, top litigation venues and policy  Read more

14 Feb 2019

The five key takeaways from the USPTO’s report on women and patents

Although female patentees are becoming more common – particularly in areas such as pharma and biotech – the rate of growth is slowing, suggesting that a lot more work needs to be done before equality between the sexes is achieved Read more

13 Feb 2019

IPBC Global 2019 is shaping up to be the biggest and best of the series so far

Senior decision makers from a wide range of companies are already confirmed to attend as demand for tickets exceeds the rate for last year's sell-out event in San Francisco  Read more

Analysis

View all
30 Mar 2019

Top five takeaways from WIPO’s 2018 PCT stats

Asia’s lead in international patent applications indicates a shift in innovation activity from West to East - and although Chinese growth is slowing the country has made big strides at a corporate and academic level Read more

29 Mar 2019

China's patent office pledges to cut pendency amid quality questions

CNIPA has promised to reduce examination times, but users are more concerned about quality. Agency's deputy director waves off the suggestion that 90% of its issued patents are 'junk' Read more

26 Mar 2019

Top state life sciences R&D deal-maker explains how to overcome patent barriers to partnerships

A*STAR’s head of IP and corporate services Suresh Sachi sets out his approach to partnering with biopharma innovators, the exclusivity-related stumbling blocks – and how to overcome them Read more

12 Mar 2019

Korean solar firm leverages patent deals to go after Chinese rivals

A pair of acquisitions and the bankruptcy of a competitor opened the door for Hanwha Q CELLS to move from licensee to plaintiff in the latest indication that disputes in the clean energy sector are heating up Read more